Leidos Holdings, Inc.

Report azionario NYSE:LDOS

Capitalizzazione di mercato: US$15.5b

Leidos Holdings Crescita futura

Criteri Future verificati 2/6

Leidos Holdings prevede che gli utili e i ricavi cresceranno rispettivamente di 5.8% e 5.3% all'anno. Si prevede che l'EPS crescerà di 8.3% all'anno. Si prevede che il ritorno sul capitale proprio sarà di 25.7% in 3 anni.

Informazioni chiave

5.8%

Tasso di crescita degli utili

8.34%

Tasso di crescita dell'EPS

Professional Services crescita degli utili15.4%
Tasso di crescita dei ricavi5.3%
Rendimento futuro del capitale proprio25.68%
Copertura analitica

Good

Ultimo aggiornamento20 May 2026

Aggiornamenti recenti sulla crescita futura

Recent updates

Seeking Alpha • May 09

Look Past Leidos Holdings' Shrinking Share Price To Its High Return On Equity

Summary Leidos Holdings is rated Buy, with a 10.4% upside target based on strong fundamentals and a widening gap between earnings and share price. LDOS's high return on equity (30.49%) and management's NorthStar 2030 strategy underpin expectations for continued growth and compounding returns. Recent price declines are attributed to macro factors like the U.S. government shutdown, not deterioration in LDOS's earnings or operational performance. Integration of ENTRUST and ongoing reliance on government contracts present risks, but improving fundamentals and guidance support a positive outlook. Read the full article on Seeking Alpha
Aggiornamento della narrazione • May 02

LDOS: Defense Tech Contracts And AI Alliance Will Offset 2026 VBA Drag

The updated analyst price target for Leidos Holdings has been trimmed by about $5 to roughly $199 per share. Analysts factored in recent target cuts around mixed Q4 results, modestly lower revenue growth assumptions, a slightly higher discount rate, and a somewhat lower future P/E multiple, even as profit margin expectations edge up.
Aggiornamento della narrazione • Apr 17

LDOS: Defense Tech And AI Partnership Will Offset 2026 VBA Headwinds

Leidos Holdings' updated analyst price target has moved lower by about $5 per share to reflect a slightly higher discount rate, a reduced future P/E assumption, and tempered margin expectations, as analysts factor in mixed Q4 results, recent target cuts from several firms, and ongoing headwinds in Veterans Benefits Administration work, even as growth initiatives continue. Analyst Commentary Recent research updates on Leidos point to a more cautious valuation framework, even as some analysts still see upside tied to growth investments and capital allocation changes.
Aggiornamento della narrazione • Apr 03

LDOS: Defense Tech And AI Contracts Will Offset 2026 VBA Slowdown

Analysts have trimmed the average price target for Leidos Holdings to $209 from about $212, reflecting slightly higher discount rate assumptions, modestly adjusted growth and margin expectations, and mixed reactions to recent Q4 results and contract headwinds. Analyst Commentary Recent research paints a mixed picture around Leidos Holdings, with both optimistic and cautious views emerging after the latest Q4 report, updated guidance, and evolving contract exposure.
Aggiornamento della narrazione • Mar 19

LDOS: Defense Tech And AI Expansion Will Offset 2026 VBA Contract Slowdown

Analysts have trimmed the blended price target on Leidos Holdings by about $1.50 to roughly $212.50, reflecting slightly softer long term growth and margin assumptions after mixed Q4 results and evolving views on the VBA headwind and defense tech opportunities. Analyst Commentary Street research on Leidos Holdings has shifted toward a more balanced view, with price targets generally nudged lower and ratings clustered around Buy, Outperform, Hold, and Neutral.
Aggiornamento della narrazione • Mar 05

LDOS: Defense Tech And AI Shift Will Offset 2026 VBA Headwinds

Analysts have reduced their blended price target for Leidos Holdings by about $4 to roughly $214, reflecting recent Q4 updates, mixed views on growth in 2026, and ongoing debate around the impact of slower Veterans Benefits Administration work versus opportunities in defense tech and other growth segments. Analyst Commentary Street research on Leidos presents a split view, with several firms trimming price targets after Q4 while still highlighting long term growth opportunities in defense technology and other higher growth areas.
Aggiornamento della narrazione • Feb 18

LDOS: Defense Tech And AI Shift Will Support Premium Multiple

The updated fair value estimate for Leidos Holdings edges down to about $218 per share from roughly $219, as analysts adjust price targets lower, citing mixed Q4 results, a slowdown in Veterans Benefits Administration activity, and tempered views on future valuation and guidance, even as the company increases its focus on higher growth markets. Analyst Commentary Recent Street research on Leidos points to a split view, with some analysts focusing on long term growth opportunities and others stressing execution risks and valuation constraints following the latest Q4 report and guidance.
Nuova narrazione • Feb 15

The Grid Modernizer: Leidos and the $2.4 Billion Bet on Sovereign AI and Energy

Leidos is entering its February 17, 2026, earnings call in a unique "valuation gap." While the stock is trading near $176 , our DCF analysis suggests an intrinsic floor of $227 , representing a 29% upside. The current market hesitation stems from "leverage shock" following the $2.4 billion acquisition of ENTRUST Solutions Group.
Aggiornamento della narrazione • Feb 04

LDOS: Entrust Acquisition And AI Partnerships Will Support Premium Multiple

Analysts nudged their blended price target on Leidos Holdings slightly higher to about US$219.31, reflecting a modestly higher assumed future P/E multiple while balancing recent target moves tied to enthusiasm around the Entrust acquisition and caution over potential 2026 contract headwinds. Analyst Commentary Recent research on Leidos highlights a split view, with some analysts leaning into the potential of the Entrust acquisition and others more focused on contract concentration and 2026 risk.
Aggiornamento della narrazione • Jan 21

LDOS: Health And Civil Strength And VA Contract Risk Will Shape Premium Multiple

Narrative Update: Leidos Holdings Analysts have trimmed their blended price target on Leidos Holdings by about $1 per share to $219, reflecting slightly more conservative assumptions on revenue growth, margins, and future P/E, after balancing recent target increases from firms citing strong execution and portfolio positioning with concerns around a key high margin contract and the timing of proving its sustainability. Analyst Commentary Recent research on Leidos highlights a mix of optimism around the core business and caution around a key contract that could affect medium term growth and valuation multiples.
Aggiornamento della narrazione • Jan 07

LDOS: Health And Civil Strength And Pipeline Visibility Will Support Premium Multiple

Analysts have nudged their fair value estimate for Leidos Holdings higher to about $219.85 from roughly $218.08, citing stronger recent earnings, solid Health & Civil margins, a 1.3x book to bill, a US$69b near term pipeline, and a view that the company merits a premium P/E multiple within government services. Analyst Commentary Bullish Takeaways Bullish analysts see the recent earnings beat as support for a higher fair value, pointing to execution in Health & Civil margins as a key driver of profitability.
Aggiornamento della narrazione • Dec 16

LDOS: Strong Health And Civil Margins Will Support Future Premium Multiple

Analysts have raised their price target on Leidos Holdings to approximately $218.08 per share from about $218.08. This reflects slightly stronger expectations for revenue growth and sustained margins, supported by robust book to bill trends, a sizable near term pipeline, and upside earnings performance with higher profitability guidance into 2025.
Aggiornamento della narrazione • Dec 02

LDOS: Strong Health And Civil Margins Will Support Continued Margin Upside

Leidos Holdings saw its average analyst price target rise from $210 to $230 as analysts highlighted robust Health & Civil margins, a strong contract pipeline, and increased profitability guidance following recent earnings results. Analyst Commentary Recent analyst reports have highlighted several factors influencing sentiment around Leidos Holdings following the latest earnings results and guidance updates.
Aggiornamento della narrazione • Nov 18

LDOS: Near-Term Contract Pipeline Will Drive Continued Margin Upside

Leidos Holdings' analyst price target has increased from $201.83 to $218.08 per share, as analysts cite strong margins in Health and Civil segments, a robust $69 billion pipeline, and raised profitability guidance as driving factors for the upward revision. Analyst Commentary Recent analyst reports have highlighted several factors that shape both the bullish and cautious outlooks for Leidos Holdings following its stronger-than-expected earnings performance and revised guidance.
Articolo di analisi • Nov 06

Leidos Holdings (NYSE:LDOS) Is Increasing Its Dividend To $0.43

Leidos Holdings, Inc. ( NYSE:LDOS ) will increase its dividend from last year's comparable payment on the 31st of...
Aggiornamento della narrazione • Nov 02

LDOS: Federal Health And Security Spending Will Drive Steady Performance Ahead

Leidos Holdings saw its analyst price target rise from approximately $198.50 to $201.83. Analysts cited the company’s ongoing momentum in health services, robust margins, and its positioning to benefit from expanding federal funding priorities.
Aggiornamento della narrazione • Oct 18

Government Funding And Digital Transformation Will Create Future Value

The average analyst price target for Leidos Holdings was raised by approximately $4 to $198.50. Analysts highlighted improving healthcare margins, stronger execution in health and defense services, and the company's positioning to benefit from recent government funding priorities.
Aggiornamento della narrazione • Oct 04

Government Funding And Digital Transformation Will Create Future Value

The analyst price target for Leidos Holdings has been increased by approximately $2 to $194.71, as analysts cite ongoing strength in healthcare margins, opportunities in defense solutions, and improved business execution as key factors supporting the higher valuation. Analyst Commentary Recent Street research updates reflect a generally positive outlook on Leidos Holdings, with multiple analysts raising their price targets and upgrading the stock in response to improved business execution and strong performance in key sectors.
Aggiornamento della narrazione • Sep 19

Government Funding And Digital Transformation Will Create Future Value

Upward analyst revisions for Leidos Holdings reflect confidence in its strategic investments in health and border security, strong healthcare margins, and effective leadership, resulting in a modest price target increase from $190.15 to $192.66. Analyst Commentary Bullish analysts highlight Leidos' strategic investments in veteran health, border security, and autonomous maritime, positioning the company to benefit from new government funding priorities.
Articolo di analisi • Sep 06

Here's Why Leidos Holdings (NYSE:LDOS) Can Manage Its Debt Responsibly

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...
Aggiornamento della narrazione • Sep 04

Government Funding And Digital Transformation Will Create Future Value

Analysts maintain a positive outlook on Leidos Holdings due to strong execution in Health Services, favorable positioning for government funding priorities, increased management confidence, and a strategic pivot toward higher-margin growth sectors, resulting in an unchanged $186.69 price target. Analyst Commentary Continued strength and solid execution within Leidos' Health Services business, contributing to improved outlook and confidence.
Articolo di analisi • Jun 19

Does Leidos Holdings (NYSE:LDOS) Deserve A Spot On Your Watchlist?

The excitement of investing in a company that can reverse its fortunes is a big draw for some speculators, so even...
Seeking Alpha • Apr 15

Leidos: A Defense Company To Consider

Summary Leidos Holdings, Inc. operates in defense, IT security, data analytics, and healthcare, recently realigning into four segments: National Security & Digital, Health & Civil, Commercial & International, and Defense Systems. Leidos has shown strong performance, boasting a 450% total return over the past decade, exceeding returns of the overall market. The company has been growing its dividend for a few years, but I think they could offer investors higher increases. Read the full article on Seeking Alpha
Seeking Alpha • Feb 02

Leidos: Fears Are Overblown, Take Advantage Of Market Uncertainty

Summary Leidos' shares have dropped significantly due to policy uncertainties, presenting a buying opportunity given its strong backlog and free cash flow generation. The company's Q3 '24 results showed robust growth with a 44% EPS increase and a $40.6 billion backlog, signaling future revenue stability. Despite political risks, Leidos' valuation is attractive at 10.3x EV/EBITDA, with strong dividend and share buyback potential. I rate Leidos a 'strong buy' due to its discounted valuation, solid financial position, and growth prospects in Health & Civil and National Security segments. Read the full article on Seeking Alpha
Seeking Alpha • Nov 22

Leidos: Not Enough Margin Of Safety Despite Creating Value In A Low Growth Sector

Summary LDOS has consistently created shareholder value through a mix of organic growth and acquisitions. Despite improving operating and capital efficiencies, LDOS's returns have not shown an improving trend, and its valuation currently does not provide enough margin of safety. LDOS is financially sound with a good reinvestment rate and cash flow. But I recommend waiting for a 15% price drop before buying. Read the full article on Seeking Alpha

Previsioni di crescita degli utili e dei ricavi

NYSE:LDOS - Stime future degli analisti e dati finanziari passati (USD Millions )
DataRicaviUtiliFlusso di cassa liberoLiquidità dell'operazioneAvg. Numero di analisti
12/31/202820,0501,6461,7942,0338
12/31/202719,1351,5461,6401,88414
12/31/202618,2331,4281,4791,80314
4/3/202617,3291,4131,8591,993N/A
1/2/202617,1741,4481,6251,750N/A
10/3/202517,3321,4051,3381,506N/A
7/4/202517,0531,4021,2821,442N/A
4/4/202516,9321,3331,2261,380N/A
1/3/202516,6621,2541,2861,435N/A
9/27/202416,2771,1991,3041,445N/A
6/28/202416,0084361,4251,593N/A
3/29/202415,7143211,1911,376N/A
12/29/202315,4381999801,187N/A
9/29/202315,155147804986N/A
6/30/202314,842708761920N/A
3/31/202314,601672661801N/A
12/30/202214,396685863992N/A
9/30/202214,1906829681,077N/A
7/1/202214,065725807913N/A
4/1/202213,916723779885N/A
12/31/202113,7377539291,033N/A
10/1/202113,498776635769N/A
7/2/202113,257734656796N/A
4/2/202112,7237181,0361,201N/A
1/1/202112,2976281,1511,334N/A
10/2/202011,9996121,3811,555N/A
7/3/202011,5926101,1471,312N/A
4/3/202011,4065939411,076N/A
1/3/202011,094667N/A992N/A
9/27/201910,787674N/A927N/A
6/28/201910,527660N/A949N/A
3/29/201910,328668N/A1,034N/A
12/28/201810,194581N/A768N/A
9/28/201810,063507N/A828N/A
6/29/20189,991442N/A724N/A
3/30/201810,033396N/A619N/A
12/29/201710,170366N/A526N/A
9/29/201710,229311N/A483N/A
6/30/20179,594320N/A486N/A
3/31/20178,311263N/A392N/A
12/30/20167,043244N/A449N/A
9/30/20165,803341N/A365N/A
7/1/20165,237299N/A364N/A
4/1/20165,206295N/A443N/A
1/1/20165,140265N/A409N/A

Previsioni di crescita futura degli analisti

Guadagni vs tasso di risparmio: La crescita prevista degli utili di LDOS ( 5.8% all'anno) è superiore al tasso di risparmio ( 3.5% ).

Guadagni vs Mercato: Si prevede che gli utili di LDOS ( 5.8% all'anno) cresceranno più lentamente rispetto al mercato US ( 16.8% all'anno).

Guadagni ad alta crescita: Si prevede che gli utili di LDOS cresceranno, ma non in modo significativo.

Ricavi vs Mercato: Si prevede che il fatturato di LDOS ( 5.3% all'anno) crescerà più lentamente rispetto al mercato US ( 11.7% all'anno).

Ricavi ad alta crescita: Si prevede che il fatturato di LDOS ( 5.3% all'anno) crescerà più lentamente di 20% all'anno.

Previsioni di crescita dell'utile per azione

Rendimento futuro del capitale proprio

ROE futuro: Si prevede che il Return on Equity di LDOS sarà elevato tra 3 anni ( 25.7 %)

Scoprire le aziende in crescita

7D

1Y

7D

1Y

7D

1Y

Analisi aziendale e situazione dei dati finanziari

DatiUltimo aggiornamento (ora UTC)
Analisi dell'azienda2026/05/22 19:08
Prezzo dell'azione a fine giornata2026/05/22 00:00
Utili2026/04/03
Utili annuali2026/01/02

Fonti dei dati

I dati utilizzati nella nostra analisi aziendale provengono da S&P Global Market Intelligence LLC. I seguenti dati sono utilizzati nel nostro modello di analisi per generare questo report. I dati sono normalizzati, il che può comportare un ritardo nella disponibilità della fonte.

PacchettoDatiTempisticaEsempio Fonte USA *
Dati finanziari della società10 anni
  • Conto economico
  • Rendiconto finanziario
  • Bilancio
Stime di consenso degli analisti+3 anni
  • Previsioni finanziarie
  • Obiettivi di prezzo degli analisti
Prezzi di mercato30 anni
  • Prezzi delle azioni
  • Dividendi, scissioni e azioni
Proprietà10 anni
  • Top azionisti
  • Insider trading
Gestione10 anni
  • Team di leadership
  • Consiglio di amministrazione
Sviluppi principali10 anni
  • Annunci aziendali

* Esempio per i titoli statunitensi, per i titoli non statunitensi si utilizzano forme e fonti normative equivalenti.

Se non specificato, tutti i dati finanziari si basano su un periodo annuale ma vengono aggiornati trimestralmente. Si tratta dei cosiddetti dati TTM (Trailing Twelve Month) o LTM (Last Twelve Month). Per saperne di più.

Modello di analisi e Snowflake

I dettagli del modello di analisi utilizzato per generare questo report sono disponibili sulla nostra pagina Github; abbiamo anche guide su come utilizzare i nostri report e tutorial su Youtube.

Scoprite il team di livello mondiale che ha progettato e realizzato il modello di analisi Simply Wall St.

Metriche di settore e industriali

Le nostre metriche di settore e di sezione sono calcolate ogni 6 ore da Simply Wall St; i dettagli del nostro processo sono disponibili su Github.

Fonti analitiche

Leidos Holdings, Inc. è coperta da 24 analisti. 14 di questi analisti ha fornito le stime di fatturato o di utile utilizzate come input per il nostro report. Le stime degli analisti vengono aggiornate nel corso della giornata.

AnalistaIstituzione
John EadeArgus Research Company
Peter ArmentBaird
David StraussBarclays